APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells

被引:75
作者
Warren, TL
Bhatia, SK
Acosta, AM
Dahle, CE
Ratliff, TL
Krieg, AM
Weiner, GJ
机构
[1] Univ Iowa, Holden Canc Ctr, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
[4] Vet Affairs Med Ctr, Iowa City, IA 52242 USA
关键词
D O I
10.4049/jimmunol.165.11.6244
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oligonucleotides containing unmethylated CpG motifs (cytosine-phosphorothioate-guanine oligodeoxynucleotide (CpG ODN)) are potent immunostimulatory agents capable of enhancing the Ag-specific Th1 response when used as immune adjuvants, We evaluated the cellular mechanisms responsible for this effect. Development of a CTL response was enhanced when mice were immunized with peptide-pulsed dendritic cells (DCs) treated with CpG ODN, However, in vitro, CpG ODN had no direct effect on highly purified T cells. In vitro, CpG ODN treatment of peptide- or protein-pulsed DCs enhanced the ability of the DCs to activate class I-restricted T cells. The presence of helper T cells enhanced this effect, indicating that treatment with CpG ODN does not obviate the role of T cell help. The enhanced ability of CpG ODN-treated DCs to activate T cells was present but blunted when Des derived from IL-12 knockout mice were used. Fixation of Ag-pulsed, CpG ODN-treated DCs limited their ability to activate T cells. In contrast, fixation had little effect on DC activation of T cells when DCs were not exposed to CpG ODN, This indicates that production of soluble factors by DCs stimulated with CpG ODN plays a particularly important role in their ability to activate class I-restricted T cells. We conclude that CpG ODN enhances the development of a cellular immune response by stimulating APCs such as DCs, to produce IL-12 and other soluble factors.
引用
收藏
页码:6244 / 6251
页数:8
相关论文
共 57 条
[1]   Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8(+) cytotoxic T lymphocytes [J].
Bachmann, MF ;
Lutz, MB ;
Layton, GT ;
Harris, SJ ;
Fehr, T ;
Rescigno, M ;
RicciardiCastagnoli, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (11) :2595-2600
[2]  
Ballas ZK, 1996, J IMMUNOL, V157, P1840
[3]  
Bendigs S, 1999, EUR J IMMUNOL, V29, P1209, DOI 10.1002/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO
[4]  
2-J
[5]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[6]   Induction of a CD8(+) cytotoxic T lymphocyte response by cross-priming requires cognate CD4(+) T cell help [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Miller, JFAP ;
Heath, WR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) :65-70
[7]  
Bohle B, 1999, EUR J IMMUNOL, V29, P2344, DOI 10.1002/(SICI)1521-4141(199907)29:07<2344::AID-IMMU2344>3.0.CO
[8]  
2-R
[9]   Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity [J].
Celluzzi, CM ;
Mayordomo, JI ;
Storkus, WJ ;
Lotze, MT ;
Falo, LD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :283-287
[10]   Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism [J].
Cho, HJ ;
Takabayashi, K ;
Cheng, PM ;
Nguyen, MD ;
Corr, M ;
Tuck, S ;
Raz, E .
NATURE BIOTECHNOLOGY, 2000, 18 (05) :509-514